TMEM4 is Highly Expressed in Plasma Cell Neoplasms and Associated with B Lymphocyte Differentiation
Journal Title: Immunological Disorders and Immunotherapy - Year 2016, Vol 1, Issue 1
Abstract
Aiming to identify biomarkers for plasma cell neoplasms, we analyzed gene expression profile and proteomic characteristics of mouse models of plasmacytomas along with other types of B-cell neoplasms. We found that transmembrane protein 4 (Tmem4) was highly expressed in plasmacytomas in comparison with early-stage B-cell neoplasms. The serum levels of Tmem4 were also significantly greater in mice with plasmacytoma comparing to those with early-stage B-cell neoplasms (P <0.01). Mechanistically, increased Tmem4 expression in B cells led to increased levels of IL-10, a cytokine that promotes the growth of malignant plasma cells and participates in the terminal differentiation of B cells into plasma cells. In addition, over-expression of Tmem4 promoted B cell terminal differentiation as evidenced by the increase in expression of XBP1, CD38, and CD138. Furthermore, we found that TMEM4 was highly expressed in plasma cells of multiple myeloma patients. These findings suggested that Tmem4 plays an important role in plasma cell differentiation and has a potential to serve as a biomarker for plasma cell neoplasms.
Authors and Affiliations
Chen-Feng Qi, Shao Xiang, Guifang Ouyang, Xing-pei Hao, Min Sun Shin, Alexander L Kovalchuk, Peng Liang, Huabao Xiong, Herbert C Morse III, Zhengping Zhuang, Jeff X Zhou and Susan K Pierce
Keywords
Related Articles
- EP ID EP743467
- DOI -
- Views 20
- Downloads 0
TMEM4 is Highly Expressed in Plasma Cell Neoplasms and Associated with B Lymphocyte Differentiation
Aiming to identify biomarkers for plasma cell neoplasms, we analyzed gene expression profile and proteomic characteristics of mouse models of plasmacytomas along with other types of B-cell neoplasms. We found that transm...
Hypertensive Emergency in Adolescent with Systemic Lupus Erythematosus at Onset: A Case Report
The severity of Systemic lupus erythematosus (SLE) at onset represents the most important biomarker of disease outcome and of treatment response in paediatric patients. Kidney disease, chronic systemic inflammation and s...
https://www.longdom.org/open-access/differential-gene-expression-of-threatened-himalayan-snow-trout-challengedwith-aeromonashydrophilla-84987.html
Objective: Curcuma has long been used as a Chinese herbal medicine for the treatment of chronic liver disease, and curcumol is its main active ingredient. This study explores the molecular mechanism of curcumol regulatin...
Atherosclerosis Biomarkers Among Egyptian Patients with Systemic Lupus Erythematosus: Population Based Study
Systemic lupus erythematosus is associated with increased risk of atherosclerosis; endothelial dysfunction is believed one of the most important initial steps of the atherosclerosis process. The aim of this study is to e...
Are TEM and CTX Beta-Lactamase Genes Common among Urinary Isolates from Ain Shams Hospital Intensive Care units?
The extended- spectrum β-lactamase producing Gram Negative bacteria are widely spread worldwide. Productions of these enzymes cause bacterial resistance to beta-lactam antibiotics as penicillin and cephalosporins. These...